Smart pen could make insulin dosing easier for teens with diabetes

NCT ID NCT05515939

Ongoing Disease control Sponsor: Wayne State University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether a Bluetooth-enabled smart insulin pen, called InPen, can help teenagers with type 1 diabetes better control their blood sugar. The device helps calculate insulin doses and tracks injections, which may reduce errors. The trial involves 34 teens aged 13-21 who use multiple daily injections and have poor blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: InPen smart insulin pen (device)
What this could lead to: If it works, this could give teens with type 1 diabetes a simpler way to manage insulin doses and improve blood sugar control.
What could go wrong: This is a small, early-stage study with only 34 participants, so results may not apply to everyone. The device is a tool, not a cure, and success depends on consistent use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Wayne State University

Detroit, Michigan, 48221, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.